Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA

NCT04104633 is registered in ClinicalTrials.gov with Centre Hospitalier Henri Duffaut - Avignon as lead sponsor.

NCT NCT04104633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04104633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
Lead sponsor
Centre Hospitalier Henri Duffaut - Avignon
Phase
Not applicable
Overall status
Completed
Start date
June 14, 2018
Completion date
June 1, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colo-rectal cancer